Clinical Outcomes After Laser Hemorrhoidoplasty
LHP
Clinical Outcomes, Pain Scores, and Patient Satisfaction in Patients Undergoing Laser Hemorrhoidoplasty: A Prospective Observational Study
1 other identifier
observational
60
1 country
1
Brief Summary
This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
July 9, 2026
July 1, 2026
7 months
March 24, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain score
Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.
At 6 hours, 24 hours, and 1 week after surgery
Secondary Outcomes (5)
Duration of postoperative analgesic use
From the day of surgery through 30 days after surgery
Length of hospital stay
From the day of surgery to hospital discharge, up to 7 days
Incidence of predefined early postoperative complications
Within 30 days after surgery
Time to return to daily activities
Up to 30 days after surgery
Patient satisfaction
Up to 3 months after surgery
Study Arms (1)
Patients undergoing laser hemorrhoidoplasty
Adults with symptomatic internal hemorrhoidal disease undergoing laser hemorrhoidoplasty.
Interventions
Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.
Eligibility Criteria
Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty at the General Surgery Clinic of Sanliurfa Education and Research Hospital.
You may qualify if:
- Age 18 years or older
- Symptomatic internal hemorrhoidal disease
- Scheduled to undergo laser hemorrhoidoplasty
- Willingness to participate and provision of informed consent
You may not qualify if:
- Grade IV hemorrhoidal disease
- Acute thrombosed hemorrhoids
- Additional anorectal pathology such as anal fissure, fistula, or perianal abscess
- History of inflammatory bowel disease or colorectal malignancy
- Previous major anal surgery'
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sanliurfa Education and Research Hospital
Sanliurfa, Şanlıurfa, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vedat Kaplan
Sanliurfa Education and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General Surgery Specialist
Study Record Dates
First Submitted
March 24, 2026
First Posted
April 9, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
July 9, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because this is a single-center study involving sensitive patient-level clinical data, and there is no pre-specified institutional mechanism for external data sharing. Only aggregated, de-identified study results will be reported.